Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-07-06 Sale | 2026-07-07 4:41 pm | Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Scientific Officer | 6,000 | $23.31 | $139,849 | 265,135 (Direct) | View |
| 2026-06-23 Sale | 2026-06-25 4:05 pm | Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Scientific Officer | 3,000 | $20 | $60,000 | 271,135 (Direct) | View |
| 2026-06-17 Sale | 2026-06-18 4:05 pm | Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Scientific Officer | 3,000 | $19 | $57,000 | 274,135 (Direct) | View |
| 2026-05-29 Sale | 2026-06-01 4:05 pm | Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Scientific Officer | 6,000 | $19.87 | $119,220 | 277,135 (Direct) | View |
| 2026-01-05 Sale | 2026-01-05 4:04 pm | Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Scientific Officer | 3,155 | $15.17 | $47,861 | 225,845 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-07-06 Exercise | 2026-07-07 4:41 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Scientific Officer | 6,000 | $6.14 | 265,135 (Direct) | View |
| 2026-07-06 Exercise | 2026-07-07 4:41 pm | N/A 2031-04-12 | Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Scientific Officer | 6,000 | $0 | 265,135 (Direct) | View |
| 2026-06-23 Exercise | 2026-06-25 4:05 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Scientific Officer | 3,000 | $6.14 | 271,135 (Direct) | View |
| 2026-06-23 Exercise | 2026-06-25 4:05 pm | N/A 2031-04-12 | Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Scientific Officer | 3,000 | $0 | 271,135 (Direct) | View |
| 2026-06-17 Exercise | 2026-06-18 4:05 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Scientific Officer | 3,000 | $6.14 | 274,135 (Direct) | View |
| 2026-06-17 Exercise | 2026-06-18 4:05 pm | N/A 2031-04-12 | Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Scientific Officer | 3,000 | $0 | 274,135 (Direct) | View |
| 2026-05-29 Exercise | 2026-06-01 4:05 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Scientific Officer | 6,000 | $6.14 | 277,135 (Direct) | View |
| 2026-05-29 Exercise | 2026-06-01 4:05 pm | N/A 2031-04-12 | Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Scientific Officer | 6,000 | $0 | 277,135 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-05 4:04 pm | N/A 2036-01-01 | Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Scientific Officer | 193,000 | $0 | 225,845 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 4:15 pm | N/A 2035-01-01 | Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Scientific Officer | 197,000 | $0 | 197,000 (Direct) | View |
| 2024-06-03 Option Award | 2024-06-05 4:10 pm | N/A 2034-06-03 | Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Scientific Officer | 40,000 | $0 | 40,000 (Direct) | View |
Ownership | 2024-06-05 4:05 pm | N/A 2030-08-14 | Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Scientific Officer | 0 | $0 | 517,851 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-04 4:31 pm | N/A 2033-01-02 | Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Technology Officer | 78,550 | $0 | 78,550 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-02 6:46 pm | N/A 2032-02-29 | Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Technology Officer | 70,000 | $0 | 70,000 (Direct) | View |